{"cik":"0000882796","ticker":"BCRX","name":"BIOCRYST PHARMACEUTICALS INC","sic_code":"2836","sic_description":"Biological Products, (No Diagnostic Substances)","exchange":"Nasdaq","state_of_incorporation":"DE","fiscal_year_end":"1231","first_filing_date":"2026-05-13","last_filing_date":"2026-06-29","url":"/sec/cik-0000882796","insider_summary":{"total_transactions":27,"unique_insiders":10,"latest_transaction":"2026-06-11"},"recent_filings":[{"accession_number":"0000093751-26-000420","form_type":"SCHEDULE 13G","form_type_family":"other","doc_date":"2026-08-07","title":"SCHEDULE 13G — BIOCRYST PHARMACEUTICALS INC — 2026-08-07","url_slug":"/sec/cik-0000882796/schedule-13g/0000093751-26-000420","edgar_url":"https://www.sec.gov/Archives/edgar/data/882796/0000093751-26-000420-index.html"},{"accession_number":"0001171843-26-005245","form_type":"S-8","form_type_family":"other","doc_date":"2026-08-05","title":"S-8 — BIOCRYST PHARMACEUTICALS INC — 2026-08-05","url_slug":"/sec/cik-0000882796/s-8/0001171843-26-005245","edgar_url":"https://www.sec.gov/Archives/edgar/data/882796/0001171843-26-005245-index.html"},{"accession_number":"0001171843-26-005223","form_type":"8-K","form_type_family":"current","doc_date":"2026-08-05","title":"8-K — BIOCRYST PHARMACEUTICALS INC — 2026-08-05","url_slug":"/sec/cik-0000882796/8-k/0001171843-26-005223","edgar_url":"https://www.sec.gov/Archives/edgar/data/882796/0001171843-26-005223-index.html"},{"accession_number":"0001628280-26-053300","form_type":"10-Q","form_type_family":"quarterly","doc_date":"2026-08-05","title":"10-Q — BIOCRYST PHARMACEUTICALS INC — 2026-08-05","url_slug":"/sec/cik-0000882796/10-q/0001628280-26-053300","edgar_url":"https://www.sec.gov/Archives/edgar/data/882796/0001628280-26-053300-index.html"},{"accession_number":"0001171843-26-005168","form_type":"8-K/A","form_type_family":"current","doc_date":"2026-08-04","title":"8-K/A — BIOCRYST PHARMACEUTICALS INC — 2026-08-04","url_slug":"/sec/cik-0000882796/8-k-a/0001171843-26-005168","edgar_url":"https://www.sec.gov/Archives/edgar/data/882796/0001171843-26-005168-index.html"},{"accession_number":"0001171843-26-004333","form_type":"8-K","form_type_family":"current","doc_date":"2026-06-29","title":"8-K — BIOCRYST PHARMACEUTICALS INC — 2026-06-29","url_slug":"/sec/cik-0000882796/8-k/0001171843-26-004333","edgar_url":"https://www.sec.gov/Archives/edgar/data/882796/0001171843-26-004333-index.html"},{"accession_number":"0001171843-26-004096","form_type":"8-K","form_type_family":"current","doc_date":"2026-06-12","title":"8-K — BIOCRYST PHARMACEUTICALS INC — 2026-06-12","url_slug":"/sec/cik-0000882796/8-k/0001171843-26-004096","edgar_url":"https://www.sec.gov/Archives/edgar/data/882796/0001171843-26-004096-index.html"},{"accession_number":"0000882796-26-000033","form_type":"4","form_type_family":"insider","doc_date":"2026-06-02","title":"4 — Milne Jill C. — 2026-06-02","url_slug":"/sec/cik-0001644246/4/0000882796-26-000033","edgar_url":"https://www.sec.gov/Archives/edgar/data/882796/0000882796-26-000033-index.html"}],"related_endpoints":{"profile":"/sec/BCRX/profile","timeline":"/sec/BCRX/timeline","peers":"/sec/BCRX/peers","insider_pulse":"/sec/BCRX/insider-pulse","insider_summary":"/sec/BCRX/insider-summary","insider_transactions":"/sec/BCRX/insider-transactions","form144":"/sec/BCRX/form144","holdings_as_filer":"/sec/BCRX/holdings","financial_facts":"/sec/BCRX/financial-facts","derivatives":"/sec/BCRX/derivatives","officers":"/sec/BCRX/officers","insider_network":"/sec/BCRX/insider-network","risk_flags":"/sec/BCRX/risk-flags","filings":"/sec/BCRX/filings","cross_topic_dossier":"/api/v1/dossier?ticker=BCRX"}}